Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

BACKGROUND: Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical features, management and outcomes for patients treated with intraveno...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaji, Aanika, Hsu, Melinda, Lin, Cheng Ting, Feliciano, Josephine, Marrone, Kristen, Brahmer, Julie R, Forde, Patrick M, Hann, Christine, Zheng, Lei, Lee, Valerie, Illei, Peter B, Danoff, Sonye K, Suresh, Karthik, Naidoo, Jarushka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797270/
https://www.ncbi.nlm.nih.gov/pubmed/33414264
http://dx.doi.org/10.1136/jitc-2020-001731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797270/
https://www.ncbi.nlm.nih.gov/pubmed/33414264
http://dx.doi.org/10.1136/jitc-2020-001731

Ejemplares similares